Foghorn Therapeutics Inc. (FHTX) stock
FHTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 10/300% above fair value
$2.05−0.04 (-1.91%)
Close on Nov 12, 2026Market cap $121.74MP/E 29.3Yield –
Foghorn Therapeutics profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Foghorn Therapeutics's profit margin for the twelve months ending Sep 30, 2026 was 8.4%. For fiscal 2025 it was -240.3%, against -383.2% the year before. The highest annual figure on record is -240.3% in fiscal 2025.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -240.3% | +142.9 |
| FY2024 | Dec 31, 2024 | -383.2% | −95.1 |
| FY2023 | Dec 31, 2023 | -288.2% | +278.1 |
| FY2022 | Dec 31, 2022 | -566.3% | +7115.3 |
| FY2021 | Dec 31, 2021 | -7681.6% | +8318.4 |
| FY2020 | Dec 31, 2020 | -16000.0% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 69.6% | +264.0 |
| Q2 FY2026 | Jun 30, 2026 | -44.7% | +192.6 |
| Q1 FY2026 | Mar 31, 2026 | -608.4% | −291.9 |
| Q4 FY2025 | Dec 31, 2025 | -234.3% | +448.6 |
| Q3 FY2025 | Sep 30, 2025 | -194.4% | +50.5 |
| Q2 FY2025 | Jun 30, 2025 | -237.3% | +96.3 |
| Q1 FY2025 | Mar 31, 2025 | -316.4% | +178.9 |
| Q4 FY2024 | Dec 31, 2024 | -682.9% | −265.0 |
| Q3 FY2024 | Sep 30, 2024 | -244.9% | −162.8 |
| Q2 FY2024 | Jun 30, 2024 | -333.6% | +193.0 |
| Q1 FY2024 | Mar 31, 2024 | -495.4% | +78.9 |
| Q4 FY2023 | Dec 31, 2023 | -417.9% | +272.5 |
| Q3 FY2023 | Sep 30, 2023 | -82.1% | +306.4 |
| Q2 FY2023 | Jun 30, 2023 | -526.6% | +81.7 |
| Q1 FY2023 | Mar 31, 2023 | -574.3% | +112.3 |
| Q4 FY2022 | Dec 31, 2022 | -690.4% | +3397.0 |
| Q3 FY2022 | Sep 30, 2022 | -388.4% | +63221.3 |
| Q2 FY2022 | Jun 30, 2022 | -608.3% | +7675.2 |
| Q1 FY2022 | Mar 31, 2022 | -686.6% | +7350.5 |
| Q4 FY2021 | Dec 31, 2021 | -4087.4% | +4182.7 |
| Q3 FY2021 | Sep 30, 2021 | -63609.8% | −53348.9 |
| Q2 FY2021 | Jun 30, 2021 | -8283.5% | – |
| Q1 FY2021 | Mar 31, 2021 | -8037.1% | – |
| Q4 FY2020 | Dec 31, 2020 | -8270.1% | – |
| Q3 FY2020 | Sep 30, 2020 | -10260.9% | – |
See a number that looks wrong?